CoagulationDisorders near Paterson, NJ

Biography: Dr. Chris Hackett received his BS in Biological Sciences from Stanford University in 2000. After doing biomedical research in industry and academia, he then pursued graduate studies in cancer genomics at the University of California, San Francisco, where he earned his PhD in 2010. Seeking to become a physician-scientist, he then earned his medical degree (MD) from the University of Minnesota in 2014. He then completed his Internal Medicine Residency at NewYork-Presbyterian/Weill Cornell Medical Center, followed by a fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center (MSK), where he focused on solid tumor oncology in the clinic and carried out laboratory research to design T cell therapies for cancer. Following fellowship, Dr. Hackett was an attending on the Cellular Therapeutics Service at MSK, where he focused on treating patients with CAR T cells, Tumor Infiltrating Lymphocytes (TIL) and other cell therapies. In 2023, he joined the Bone Marrow Transplant Service at Weill Cornell Medicine and NewYork-Presbyterian Hospital, where he continues to both treat patients with cellular therapies and conduct research to develop new cell therapies for solid tumors.

Biography: Lisa Nathan, MD, MPH is theChief of Obstetrics, Sloane Hospital for Women, Columbia University Irving Medical Center and an Associate Professor of Obstetrics & Gynecology in the Department of Obstetrics and Gynecology at CUMC. She completed her Ob/Gyn residency training at Montefiore/Einstein and stayed on to work for several years as an academic generalist. During this time, she founded the Global Women's Health Program for the Department with grant support from the Einstein Global Health Center and the U.S. Fulbright African Regional Research Program. Dr. Nathan also founded Einstein's Departmental Health Equity Task Force. The goal of this task force was to create a Departmental culture and workforce that understands the concepts of health disparities and structural racism, recognizes the ways in which society and the health system promote them, and works proactively to dismantle them. In addition to her clinical and administrative duties, Dr Nathan is also active within ACOG, where she is a member of the Safe Motherhood Initiative Steering Committee. She was the Chair of the Maternal Sepsis Bundle workgroup and is a current member of the Health Equity Subcommittee. She also serves as a consultant to the New York City Department of Health, where she serves as the Co-Chair of the Maternal Mortality Review Committee. In this role, she reviews events leading to maternal mortality for the majority of cases occurring in New York City. These reviews form the basis for the development of recommendations for city and state level initiatives to combat the root causes of the high maternal mortality rates in New York City.

Biography: Dr. Stergios Zacharoulis, MD is an Oncology Specialist who practices in New York, NY. He is 55 years old and has been practicing for 30 years. Dr. Stergios Zacharoulis, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center and Newyork-Presbyterian/Morgan Stanley Children's Hospital.

Biography: Mariam El-Ashmawy, MD PhD is a medical oncologist andtranslational scientist with specialization in the treatment of advanced skincancer and ocular melanoma. Her research investigates the complex geneticlandscape of cancer in order to develop new therapies. In the laboratory, her work has been dedicated to understanding the complex genomic landscape of cancer and developing novel targeted therapeutic strategies. Her ongoing projects include testing novel RAS pathway inhibitors in preclinical models of gastric and esophageal cancer as well as a first-in-human clinical trials for patients with NRAS mutant melanoma.

Biography: Dr. Joel Gabre, MD is an Oncology Specialist who practices in New York, NY. He is 39 years old and has been practicing for 13 years. Dr. Joel Gabre, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Chen is an Assistant Professor of Medicine and medical oncologist specializing in the treatment of thoracic cancers including non-small cell lung cancer, small cell lung cancer, and mesothelioma. She received her bachelor's degree in molecular biology from Princeton University and completed her medical degree at the University of Pennsylvania, where she was inducted into the Alpha Omega Alpha Honor Society. She completed both her internal medicine residency and medical oncology fellowship at Columbia University, where she served as Chief Fellow. In addition to her clinical responsibilities, Dr. Chen has an interest in identifying novel therapies through clinical trials for patients with lung cancer and other tumor types. She received the Journal of Clinical Oncology Young Investigator Award from the American Society of Clinical Oncology in recognition of her work. Above all, Dr. Chen values her relationships with patients and their families and is dedicated to providing compassionate care that is tailored to each patient. She is proud to be part of a multidisciplinary team that works tirelessly to support patients and improve their survival and well-being.

Biography: Dr. Timothy Wang is a leading expert in gastroenterology cancer research and patient care. His research specifically focuses on transgenic/ knockout mice, stem cells, lineage tracing, bone marrow-derived cells, and FACS analysis of immune/epithelial cells in the gut. His laboratory has for decades investigated the molecular mechanisms of gastrointestinal carcinogenesis, and has been continuously funded by the NIH for 29 years and by the NCI for 14 years. His lab has worked for many years on the role of inflammation in promoting gastrointestinal neoplasia, including colon cancer. His research has defined key roles for stromal cells in tumor development, including myeloid cells. Dr. Wang is the GI Division Chief at Columbia and serves as Co-leader of the Tumor Biology and Microenvironment Program of the Herbert Irving Comprehensive Cancer Center. He also serves as director of the Columbia University NCI U54 Tumor Microenvironment (TMEN) program and directs the Barretts Esophageal Translational Research Network (BETRNet) program and the Intestinal Stem Cell Consortium (ISCC) at Columbia. In addition to his leadership at Columbia, Dr. Wang has served as President of the American Gastroenterology Association (AGA). His work has been recognized with numerous awards, including the Outstanding Investigator Award from the NCI, the Irene and Arthur Fishberg Prize for medical research, the Ruth Leff Siegel Award for pancreatic cancer research, and the William Beaumont Prize in Gastroenterology from the AGA. Over his career, he has organized numerous conferences, including conferences on Gastrin, Regulatory Peptides, AACR Symposium on Gastric Cancer, Tumor Microenvironment, and Keystone Conferences.

Biography: Dr. Sathe completed her Residency in Internal Medicine at NYP/Weill Cornell and is a graduate of Rutgers-New Jersey Medical School. She also holds a JD from Columbia Law School. Her research focuses on improving cancer care delivery and reducing disparities in treatment and outcomes.